Entdecken Sie die besten Kosten und Kliniken für die Behandlung von dem Typ-1-Diabetes in der Republik Korea 2026

South Korea National Health Insurance does not cover Type 1 Diabetes treatment for medical tourists. This system serves citizens and residents staying over 6 months. Visitors pay full unsubsidized rates for insulin and consultations. International patients must pay all medical costs out of pocket.

• Insurance eligibility: Eligibility requires 6 months of residency and official registration.
• Consultation costs: Specialist visits in Seoul clinics cost from $36 to $109.
• Medication access: Local pharmacies require a Korean prescription for all insulin types.
• Advanced therapies: Specialized centers like RE:YOUTH offer arterial stem cell regenerative treatments.

Bookimed Expert Insight: Advanced regenerative therapies are increasingly accessible for chronic conditions in Korea. RE:YOUTH serves approximately 1,000 patients annually using specialized arterial stem cell protocols. While traditional NHI coverage is absent, these specialized clinics offer high-priority care. They often limit daily intake to 2 patients for intensive medical attention.

Patient Consensus: Patients note that while the national system is closed to visitors, pharmacy access is efficient. They emphasize confirming all billing and prescription requirements before arriving to ensure steady insulin supplies.

To refill Humalog or Lantus in South Korea, you must obtain a new prescription from a local physician. Foreign prescriptions are not legally valid at Korean pharmacies. Visit an endocrinology department at a university hospital or a local medical clinic for a consultation first.

• Clinic consultation: Visit a local endocrinology clinic or hospital to receive a valid Korean prescription.
• Required documentation: Bring your passport, original prescription bottles, and a letter from your home physician.
• Pharmacy location: Purchase insulin at hospital-linked pharmacies, as small street-level pharmacies may not stock it.
• Out-of-pocket costs: Prepare for full-price payments if you do not have Korean National Health Insurance.

Bookimed Expert Insight: While small clinics can issue prescriptions, visiting integrated networks like Soon Chun Hyang University Hospital is safer. These large centers have over 100 doctors and multidisciplinary departments. They are better equipped to handle international medical summaries and ensure insulin brand availability. If local pharmacies lack your specific brand, hospital-based pharmacies in Seoul or Cheonan typically maintain larger refrigerated inventories.

Patient Consensus: Patients note it is important to bring written summaries because explaining dosing and insulin types can be difficult. They suggest carrying extra supplies as getting set up with a local doctor can take time.

Top medical centers in Seoul for Type 1 Diabetes include Asan Medical Center, Seoul National University Hospital, and Samsung Medical Center. These JCI-accredited tertiary hospitals provide English-speaking coordinators. They specialize in insulin pump management and advanced endocrinology within dedicated international healthcare centers.

• Endocrinology expertise: Specialized departments manage glucose stabilization and advanced tech.
• Language support: International centers provide dedicated English-speaking staff for consultations.
• Diagnostic tools: Facilities offer retinal nerve fiber layer measurement for complications.
• Clinical volume: Large hospitals like Soon Chun Hyang serve thousands annually.

Bookimed Expert Insight: Korea ranks 7th globally in our medical travel data. While large university hospitals are excellent for standard care, RE:YOUTH clinic offers specialized arterial stem cell therapy. This clinic limits intake to 2 patients daily. This ensures high-level focus for complex chronic cases.

Patient Consensus: Patients emphasize using international clinics rather than general desks for booking. Many recommend bringing recent A1c results and English medication lists to the first appointment.

Continuous Glucose Monitors (CGM) and insulin pumps in South Korea are generally covered by National Health Insurance. Reimbursement typically covers 70% of costs for Type 1 Diabetes patients. International patients usually pay out-of-pocket unless they are registered in the national health system. Documentation and prescriptions are mandatory for all claims.

• Reimbursement rate: National insurance typically covers 70% of costs for eligible patients.
• Eligibility criteria: Coverage applies to Type 1 Diabetes patients with a doctor prescription.
• Required materials: Patients must submit claims for sensors, transmitters, and insulin pump supplies.
• Included devices: Coverage includes most major CGM brands and qualified insulin pump models.

Bookimed Expert Insight: While university hospitals like Soon Chun Hyang manage standard device prescriptions, regenerative clinics like RE:YOUTH focus on arterial stem cell therapy. Patients should note that specialized treatments or experimental therapies often fall outside standard reimbursement protocols. Always confirm if your specific hospital pathway supports direct billing for these devices.

Patient Consensus: Patients note that coverage is often partial rather than total. They emphasize that ongoing costs for sensors and infusion sets frequently remain a significant monthly expense.

Travelers to the Republic of Korea may bring a 3-month insulin supply for personal use. You must carry a doctors letter and original prescriptions. Notify customs officers if you carry syringes. Larger quantities require pre-approval from the Ministry of Food and Drug Safety.

• Supply limit: Import up to a 90-day supply without advance Ministry permission.
• Documentation needs: Carry an English doctors letter stating diagnosis and required medications.
• Storage safety: Store all insulin in carry-on bags to avoid freezing temperatures.
• Transit rule: Inform security about pumps or CGMs before passing through scanners.

Bookimed Expert Insight: While most travelers bring standard supplies, South Korea is a hub for advanced regenerative medicine. RE:YOUTH clinic offers unique arterial stem cell therapy for chronic conditions. They limit intake to 2 patients daily to ensure high-level focus. This personalized approach is rare in larger hospitals like Soon Chun Hyang University Hospital.

Patient Consensus: Patients recommend packing 3 times the expected supply and splitting it between two bags. Keeping a Korean translation card for diabetes and emergency contacts helps during unexpected transit delays.

South Korea offers high-end diabetes technology including local EOPatch and Dana-i pumps alongside global Medtronic MiniMed systems. Dexcom G6/G7 and Abbott FreeStyle Libre 2/3 sensors are widely available. Major insulin analogs like NovoRapid, Humalog, and Lantus are stocked at university hospitals.

• Insulin pumps: Local brands include EOPatch tubeless pumps and SOOIL Dana-i tubed systems.
• CGM systems: Dexcom G6, G7, Abbott FreeStyle Libre, and Medtronic Guardian sensors are standard.
• Insulin brands: Novo Nordisk, Eli Lilly, and Sanofi analogs are available at hospital pharmacies.
• Local monitoring: Korean manufacturer i-SENS produces domestic glucose monitoring technology for local patients.

Bookimed Expert Insight: While advanced tech like stem cell therapy is available in cities like Cheonan for around $18,500 to $33,000, daily management relies on hospital-specific stock. Major university hospitals like Soon Chun Hyang have specialized pharmacies that carry a much broader range of global insulin brands than smaller private clinics.

Patient Consensus: Patients emphasize that maintaining a steady supply of specific infusion sets is more challenging than finding the pump itself. Many suggest bringing a backup insulin plan because local pharmacies might not stock your exact brand during a shortage.

Korean endocrinology centres provide structured education through multidisciplinary teams for newly diagnosed Type 1 patients. Programmes like the T1DE curriculum focus on intensive management. Specialist nurses and dietitians lead these sessions at JCI-accredited facilities. They cover insulin therapy and continuous glucose monitoring technology.

• Multidisciplinary care: Teams include endocrinologists, specialized nurses, and certified dietitians.
• Clinical modules: Training covers carbohydrate counting, insulin titration, and hypoglycemia management.
• Technology integration: Programs teach patients to interpret data from continuous glucose monitors.
• Institutional reach: Major university hospitals generally offer more formal diagnosis pathways than clinics.

Bookimed Expert Insight: Patient volume impacts education quality in South Korea. Soon Chun Hyang University Hospital operates four major centers across the country. Such large hospital systems typically employ dedicated diabetes educators. These specialists provide more intensive one-on-one training than smaller private clinics focus on.

Patient Consensus: Patients note that education is often practical and hands-on rather than classroom-based. Many emphasize that bringing specific questions about technology helps secure better training from nurses.